BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23858558)

  • 1. A pilot study for preoperative concurrent chemoradiotherapy with S-1 and cisplatin for locally advanced gastric cancer.
    Chung MJ; Kim H; Jung YS; Shin SK; Hyung WJ; Noh SH; Seong J; Lee YC; Song SY
    Hepatogastroenterology; 2013; 60(122):382-6. PubMed ID: 23858558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
    Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
    Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
    Yamaguchi M; Toyokawa G; Ohba T; Sasaki T; Kometani T; Hamatake M; Hirai F; Taguchi K; Yamanaka T; Seto T; Takenoyama M; Sugio K; Ichinose Y
    Ann Thorac Surg; 2013 Nov; 96(5):1783-9. PubMed ID: 23998404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01).
    Takahashi T; Saikawa Y; Takaishi H; Takeuchi H; Wada N; Oyama T; Fukuda K; Fukada J; Kawaguchi O; Shigematsu N; Kitagawa Y
    Anticancer Res; 2011 Sep; 31(9):3079-83. PubMed ID: 21868563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
    Takahashi T; Saikawa Y; Yoshida M; Kitagawa Y; Otani Y; Kubota T; Kumai K; Kitajima M
    Anticancer Res; 2006; 26(2B):1631-5. PubMed ID: 16619584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.
    Iwase H; Shimada M; Tsuzuki T; Hirashima N; Okeya M; Hibino Y; Ryuge N; Yokoi M; Kida Y; Kuno T; Tanaka Y; Kato B; Esaki M; Urata N; Kato E
    Oncology; 2013; 84(6):342-9. PubMed ID: 23689040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer.
    Fujitani K; Hasegawa H; Hirao M; Kurokawa Y; Tsujinaka T
    Anticancer Res; 2011 Sep; 31(9):3085-91. PubMed ID: 21868564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer.
    Saikawa Y; Kubota T; Kumagai K; Nakamura R; Kumai K; Shigematsu N; Kubo A; Kitajima M; Kitagawa Y
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):173-9. PubMed ID: 17996385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-.
    Matsuda S; Takahashi T; Fukada J; Fukuda K; Kawakubo H; Saikawa Y; Kawaguchi O; Takeuchi H; Shigematsu N; Kitagawa Y
    Radiat Oncol; 2014 Jan; 9():9. PubMed ID: 24398302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
    Kato M; Onishi H; Matsumoto K; Tsuruta N; Higuchi K; Motoshita J; Katano M
    Anticancer Res; 2012 Nov; 32(11):5099-104. PubMed ID: 23155287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.
    Lee DJ; Sohn TS; Lim DH; Ahn HK; Park SH; Lee J; Park JO; Park YS; Lim HY; Choi DI; Kim KM; Choi MG; Noh JH; Bae JM; Kim S; Min BH; Kang WK
    Cancer Chemother Pharmacol; 2012 May; 69(5):1333-8. PubMed ID: 22311161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
    Iwase H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.
    Kawaguchi T; Takada M; Ando M; Okishio K; Atagi S; Fujita Y; Tomizawa Y; Hayashihara K; Okano Y; Takahashi F; Saito R; Matsumura A; Tamura A
    Eur J Cancer; 2012 Mar; 48(5):672-7. PubMed ID: 22172569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
    Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
    Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.
    Chang H; Shin SK; Cho BC; Lee CG; Kim CB; Kim DJ; Lee JG; Hur J; Lee CY; Bae MK; Kim HR; Lee SK; Park JC; Lee H; Kim HI; Chung H; Cha J; Lee YC; Kim JH
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):665-71. PubMed ID: 24562525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.
    Yunokawa M; Katsumata N; Yamamoto H; Kodaira M; Yonemori K; Shimizu C; Ando M; Tamura K; Fujiwara Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1369-74. PubMed ID: 23558943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.